Cellectar Biosciences Inc (CLRB)
3.17
+0.07
(+2.26%)
USD |
NASDAQ |
May 01, 16:00
3.17
0.00 (0.00%)
After-Hours: 17:54
Cellectar Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.00 |
June 30, 2008 | 0.00 |
March 31, 2008 | 0.00 |
December 31, 2007 | 0.00 |
Date | Value |
---|---|
September 30, 2007 | 0.00 |
June 30, 2007 | 0.00 |
March 31, 2007 | 0.00 |
December 31, 2006 | 0.00 |
September 30, 2006 | 0.00 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
December 31, 2005 | 0.00 |
September 30, 2005 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Perspective Therapeutics Inc | 0.0229 |
Eli Lilly and Co | 2.342 |
Actinium Pharmaceuticals Inc | 0.00 |
Bristol-Myers Squibb Co | 3.376 |
Altimmune Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 12.08M |
Total Liabilities (Quarterly) | 13.43M |
Shareholders Equity (Quarterly) | -1.356M |